WEBULL

This Xspray Pharma Insider Increased Their Holding By 14% Last Year

Simply Wall St · 06/28 08:06

Viewing insider transactions for Xspray Pharma AB (publ)'s (STO:XSPRAY ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Xspray Pharma Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by Director Anders Bladh for kr4.8m worth of shares, at about kr45.82 per share. That means that an insider was happy to buy shares at around the current price of kr45.90. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the Xspray Pharma insider decided to buy shares at close to current prices. Anders Bladh was the only individual insider to buy shares in the last twelve months.

Anders Bladh purchased 106.57k shares over the year. The average price per share was kr46.31. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for Xspray Pharma

insider-trading-volume
OM:XSPRAY Insider Trading Volume June 28th 2025

Xspray Pharma is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that Xspray Pharma insiders own about kr76m worth of shares (which is 4.5% of the company). We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Do The Xspray Pharma Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. Overall we don't see anything to make us think Xspray Pharma insiders are doubting the company, and they do own shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Xspray Pharma. To that end, you should learn about the 4 warning signs we've spotted with Xspray Pharma (including 2 which can't be ignored).

Of course Xspray Pharma may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.